AUTL
Price
$2.31
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
617.44M
32 days until earnings call
ONC
Price
$241.23
Change
-$13.26 (-5.21%)
Updated
Jun 27 closing price
Capitalization
28.04B
54 days until earnings call
Interact to see
Advertisement

AUTL vs ONC

Header iconAUTL vs ONC Comparison
Open Charts AUTL vs ONCBanner chart's image
Autolus Therapeutics
Price$2.31
Change-$0.00 (-0.00%)
Volume$2.13K
Capitalization617.44M
BeOne Medicines
Price$241.23
Change-$13.26 (-5.21%)
Volume$400.83K
Capitalization28.04B
AUTL vs ONC Comparison Chart in %
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. ONC commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Buy and ONC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AUTL: $2.31 vs. ONC: $241.23)
Brand notoriety: AUTL and ONC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 0% vs. ONC: 115%
Market capitalization -- AUTL: $617.44M vs. ONC: $28.04B
AUTL [@Biotechnology] is valued at $617.44M. ONC’s [@Biotechnology] market capitalization is $28.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 0 FA rating(s) are green whileONC’s FA Score has 0 green FA rating(s).

  • AUTL’s FA Score: 0 green, 5 red.
  • ONC’s FA Score: 0 green, 5 red.
According to our system of comparison, AUTL is a better buy in the long-term than ONC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 3 TA indicator(s) are bullish while ONC’s TA Score has 4 bullish TA indicator(s).

  • AUTL’s TA Score: 3 bullish, 5 bearish.
  • ONC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ONC is a better buy in the short-term than AUTL.

Price Growth

AUTL (@Biotechnology) experienced а +12.14% price change this week, while ONC (@Biotechnology) price change was -2.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

AUTL is expected to report earnings on Jul 31, 2025.

ONC is expected to report earnings on Aug 22, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($28B) has a higher market cap than AUTL($617M). ONC YTD gains are higher at: 30.599 vs. AUTL (-1.702). ONC has higher annual earnings (EBITDA): -116.48M vs. AUTL (-226.02M). ONC has more cash in the bank: 2.52B vs. AUTL (517M). AUTL has less debt than ONC: AUTL (57.7M) vs ONC (997M). ONC has higher revenues than AUTL: ONC (4.18B) vs AUTL (9.01M).
AUTLONCAUTL / ONC
Capitalization617M28B2%
EBITDA-226.02M-116.48M194%
Gain YTD-1.70230.599-6%
P/E RatioN/AN/A-
Revenue9.01M4.18B0%
Total Cash517M2.52B21%
Total Debt57.7M997M6%
FUNDAMENTALS RATINGS
AUTL vs ONC: Fundamental Ratings
AUTL
ONC
OUTLOOK RATING
1..100
3363
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
4045
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUTL's Valuation (40) in the Biotechnology industry is in the same range as ONC (58). This means that AUTL’s stock grew similarly to ONC’s over the last 12 months.

ONC's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as AUTL (100). This means that ONC’s stock grew similarly to AUTL’s over the last 12 months.

ONC's SMR Rating (93) in the Biotechnology industry is in the same range as AUTL (97). This means that ONC’s stock grew similarly to AUTL’s over the last 12 months.

AUTL's Price Growth Rating (40) in the Biotechnology industry is in the same range as ONC (45). This means that AUTL’s stock grew similarly to ONC’s over the last 12 months.

AUTL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ONC (100). This means that AUTL’s stock grew similarly to ONC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AUTLONC
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FZABX30.150.32
+1.07%
Fidelity Advisor Diversified Intl Z
HAGCX53.310.23
+0.43%
Carillon Eagle Mid Cap Growth C
VYMQX18.500.07
+0.38%
Voya Mid Cap Research Enhanced Index A
NWXQX16.340.05
+0.31%
Nationwide Mid Cap Market Idx Instl Svc
VIKSX11.250.02
+0.18%
Virtus KAR Small-Mid Cap Growth I

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
N/A
OCUL - AUTL
50%
Loosely correlated
-2.54%
CRSP - AUTL
49%
Loosely correlated
N/A
IDYA - AUTL
45%
Loosely correlated
-4.13%
SCPH - AUTL
44%
Loosely correlated
-2.76%
ERAS - AUTL
44%
Loosely correlated
N/A
More

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
-5.21%
ZLAB - ONC
55%
Loosely correlated
-3.87%
TCRX - ONC
34%
Loosely correlated
-5.41%
RGNX - ONC
33%
Poorly correlated
-4.11%
IPSC - ONC
31%
Poorly correlated
-5.74%
AUTL - ONC
31%
Poorly correlated
N/A
More